Renocrit 10000 IU Injection
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Renocrit 10000 IU Injection contains recombinant human erythropoietin alfa, an erythropoiesis-stimulating agent. Its labelling describes it for the treatment of anaemia associated with chronic kidney disease (CKD) and myelodysplastic syndromes, and for anaemia caused by cancer chemotherapy. It is described as stimulating the bone marrow to produce more red blood cells and is given by a healthcare professional.
Product Information
The following description reflects information associated with recombinant human erythropoietin alfa and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of anaemia associated with chronic kidney disease
- Described for the treatment of anaemia in myelodysplastic syndromes
- Described for the treatment of anaemia caused by cancer chemotherapy
- Described as stimulating the bone marrow to produce more red blood cells
Described Dosage & Administration
- Administered only by a doctor or nurse as an injection — not self-administered
- The dose is described as based on body weight and the cause of the anaemia
- Taking iron supplements before and during treatment is described as helping the treatment work
- Stored in a refrigerator; it should not be frozen
Described Side Effects
Commonly described side effects include:
- High blood pressure
- Headache
- Joint pain
- Nausea and vomiting
- Flu-like symptoms
These are described as usually short-lived as the body adjusts. Serious blood clotting is described as a risk that may require immediate medical attention; any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- The doctor should be told about any high blood pressure, heart disease, or gout
- The doctor should be told about all other medicines being taken that might interact with this medicine
- Frequent blood-pressure checks and other tests are described as recommended during treatment
- Pregnant women and breastfeeding mothers should inform their doctor before starting treatment
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains recombinant human erythropoietin alfa and is used to treat anaemia associated with chronic kidney disease, myelodysplastic syndromes, and cancer chemotherapy, by stimulating red blood cell production. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling states it is administered by a doctor or nurse as an injection, at a dose based on body weight and the cause of the anaemia. It is stored refrigerated and must not be frozen.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.